| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |